Open Access<p>Real-World Safety And Effectiveness Of OnabotulinumtoxinA Treatment Of Crow’s Feet Lines And Glabellar Lines: Results Of A Korean Postmarketing Surveillance Study</p>
Author(s) -
Dong-Jin Yi,
Seong-Jin Hwang,
Junhyuk Son,
Irina Yushmanova,
Krystal Anson Spenta,
S. St. Rose
Publication year - 2019
Publication title -
clinical, cosmetic and investigational dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 35
ISSN - 1178-7015
DOI - 10.2147/ccid.s227493
Subject(s) - medicine , adverse effect , postmarketing surveillance , korean population , pediatrics
OnabotulinumtoxinA is approved in the Republic of Korea for the treatment of moderate-to-severe crow's feet lines (CFL) and glabellar lines (GL), separately or in combination. We assessed safety and effectiveness of onabotulinumtoxinA in real-world clinical practice.